Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2015 056 571.1 |
96 | EP file number | EAKZ | 15 78 9718.2 |
86 | WO file number | WAKZ | PCT/US2015/029926 |
97 | EP publication number | EPN | 3139949 |
87 | WO publication number | WPN | 2015172046 |
54 | Designation/title | TI | ZUSAMMENSETZUNGEN ENTHALTEND EIN VIP-ELP FUSIONSPROTEIN ZUR VERWENDUNG IN DER BEHANDLUNG VON MUKOVISZIDOSE |
51 | IPC main class | ICM (ICMV) | A61K 38/22 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 38/39 (2006.01), A61K 31/404 (2006.01), A61K 31/443 (2006.01), A61P 11/00 (2006.01) |
22 | DE application date | DAT | May 8, 2015 |
96 | EP application date | EAT | May 8, 2015 |
86 | WO application date | WAT | May 8, 2015 |
43 | Date of first publication | OT | Nov 12, 2015 |
| Date of publication of grant | PET | Jul 29, 2020 |
71/73 | Applicant/owner | INH | Phasebio Pharmaceuticals, Inc., Malvern, Pa., US |
72 | Inventor | IN | ARNOLD, Susan, Malvern, Oregon 19355-1423, US; BALLANCE, David James, Malvern, Pennsylvania 19355-1423, US |
| Address for service | | RWS Group, Translation Division, CHALFONT ST PETER, Bucks SL9 9FG, GB |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201461990425 P May 8, 2014
|
| Due date | FT FG | May 31, 2026 Annual fee for the 12th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003139949A1 Searchable text:
EP000003139949A1 Original document:
EP000003139949B1 Searchable text:
EP000003139949B1 Original document:
WO002015172046 Searchable text:
WO002015172046 |
43 | Date of first publication | EVT | Nov 12, 2015 |
| Date of the first transfer into DPMAregister | EREGT | Mar 16, 2017 |
| Date of the (most recent) update in DPMAregister | REGT | May 7, 2025 (Show all update days)(Hide all update days)- May 7, 2025
- Due date: changed
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 29.07.2020: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 29.07.2020: deleted
- Sep 19, 2024
- St.36: changed (technical change)
- Jun 8, 2024; Apr 30, 2024; May 10, 2023; Jun 9, 2022; Jul 22, 2021; Jun 17, 2021; Jun 8, 2021; Oct 23, 2020; Aug 20, 2020; Jul 10, 2020; Jul 9, 2020; Feb 13, 2020; Apr 27, 2017
- Historical data not available for this/these date(s)
- Mar 16, 2017
- Date of the first transfer into DPMAregister
|